IRIS
COLOMBO, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.514
AS - Asia 12.699
EU - Europa 7.960
SA - Sud America 1.627
AF - Africa 517
Continente sconosciuto - Info sul continente non disponibili 235
OC - Oceania 28
Totale 36.580
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.149
SG - Singapore 4.496
CN - Cina 4.016
VN - Vietnam 1.769
IE - Irlanda 1.442
FI - Finlandia 1.384
BR - Brasile 1.283
SE - Svezia 1.209
HK - Hong Kong 858
UA - Ucraina 834
DE - Germania 804
IT - Italia 762
TR - Turchia 493
FR - Francia 406
ZA - Sudafrica 390
NL - Olanda 372
GB - Regno Unito 267
BD - Bangladesh 252
CA - Canada 238
IN - India 164
RU - Federazione Russa 150
AR - Argentina 140
KR - Corea 116
MX - Messico 76
IQ - Iraq 72
JP - Giappone 52
AT - Austria 51
PK - Pakistan 50
ES - Italia 49
EC - Ecuador 46
CO - Colombia 45
ID - Indonesia 45
PH - Filippine 44
BE - Belgio 43
PL - Polonia 43
UZ - Uzbekistan 37
MA - Marocco 31
TW - Taiwan 31
VE - Venezuela 30
CZ - Repubblica Ceca 29
TH - Thailandia 29
EU - Europa 26
IR - Iran 24
AU - Australia 22
PY - Paraguay 22
CL - Cile 21
JO - Giordania 20
MY - Malesia 20
PE - Perù 17
UY - Uruguay 17
KE - Kenya 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 15
PT - Portogallo 15
EG - Egitto 14
IL - Israele 13
LT - Lituania 13
SA - Arabia Saudita 13
AZ - Azerbaigian 12
AL - Albania 11
ET - Etiopia 11
RO - Romania 11
HN - Honduras 10
KZ - Kazakistan 10
RS - Serbia 10
TN - Tunisia 10
SN - Senegal 8
BY - Bielorussia 7
HR - Croazia 7
BG - Bulgaria 6
GR - Grecia 6
JM - Giamaica 6
YE - Yemen 6
BO - Bolivia 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
GA - Gabon 5
LB - Libano 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
BH - Bahrain 4
CH - Svizzera 4
MD - Moldavia 4
NI - Nicaragua 4
NO - Norvegia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
DK - Danimarca 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
PS - Palestinian Territory 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
Totale 36.334
Salva come PNG Salva come JPEG
Città #
Singapore 2.092
Ashburn 1.442
Dublin 1.440
Chandler 1.342
San Jose 1.310
Beijing 1.042
Jacksonville 1.004
Santa Clara 896
Hong Kong 818
Dearborn 540
Ho Chi Minh City 523
Council Bluffs 521
Nanjing 474
Dallas 430
Boardman 425
Hanoi 413
Izmir 398
Johannesburg 375
Princeton 314
Lauterbourg 271
Ann Arbor 252
Los Angeles 250
San Mateo 239
Parma 206
Wilmington 202
Hefei 200
Shanghai 188
Shenyang 175
Helsinki 155
New York 153
Kunming 147
Nanchang 140
Toronto 136
Munich 135
Jinan 132
Hebei 119
São Paulo 117
Moscow 105
Buffalo 95
Jiaxing 84
Seoul 84
Columbus 81
Tianjin 80
Bremen 79
Guangzhou 74
Woodbridge 74
Changsha 73
Seattle 73
Da Nang 71
The Dalles 71
Grafing 70
Haiphong 70
Milan 69
Marseille 64
Des Moines 62
Brooklyn 51
Zhengzhou 49
Houston 47
Turku 43
Kocaeli 41
Rome 40
Brussels 39
Vienna 38
London 37
Rio de Janeiro 36
Norwalk 35
Atlanta 34
Orem 34
Phoenix 32
Stockholm 32
Warsaw 31
Bologna 30
Chennai 30
Brasília 29
San Francisco 29
Tashkent 29
Pune 28
Tokyo 28
Belo Horizonte 27
Frankfurt am Main 27
Hải Dương 27
Montreal 27
Ningbo 27
Can Tho 26
Fremont 26
Hangzhou 26
Brno 25
Chicago 25
Jakarta 24
Baghdad 23
Curitiba 23
Chengdu 22
Denver 21
Amsterdam 20
Haikou 20
Ottawa 20
Poplar 20
Manchester 19
Mexico City 19
Amman 18
Totale 21.729
Salva come PNG Salva come JPEG
Nome #
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 399
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
A process and an apparatus for administering a predefined amount of a compound 243
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 228
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 206
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 206
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 205
Mechanisms of formation and disintegration of alginate beads obtained by prilling 193
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 185
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 181
Alginate containing formulations: are they all the same? 181
MULTILAYERED PHARMACEUTICAL FORMULATION 176
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 175
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 172
Solid-state characterization of tobramycin powders for inhalation 172
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 171
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 170
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 169
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 169
Assemblage of novel release modules for the development of adaptable drug delivery systems 167
Bioadhesive film for dermal and transdermal drug delivery” 165
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 165
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 165
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 165
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 163
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 163
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 162
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 162
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 162
Validation of a clean-in-place system on a capsule filling machine 161
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 161
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 161
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 160
Bioadhesive transdermal film containing caffeine 159
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 157
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 155
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 154
A novel spray dried formulation for pulmonary administration of insulin 153
A drug powder for inhalation administration and a process thereof 153
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 153
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 153
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 152
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 151
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 151
Flexibility and drug release features of lipid/saccharide nanoparticles 150
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 150
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 150
A rheometric method for assessing the sucralfate mucin interaction 149
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 149
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 148
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 148
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 147
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 146
Effect of Drying Methods on Retention of Moist Sucralfate Gel Properties 146
Film for active ingredients dermal and transdermal administration 146
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 146
Les formes pharmaceutiques du futur 145
Assembled modules technology for site-specific prolonged delivery of norfloxacin 145
Disintegration Propensity of Tablets evaluated by Means of Disintegration Force Kinetics 145
The Surface Roughness of Lactose Particles Can Be Modulated by Wet- Smoothing Using a High-Shear Mixer 144
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 144
Characterization of the permselective properties of rabbit skin during transdermal iontophoresis 143
Preparation of poly(methacrylic acid-g-poly(ethylene glycol) nanospheres from methacrylic monomers for pharmaceutical applications 143
A physical analysis of the phenomenon of tablet disintegration 143
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 141
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 140
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 140
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 139
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 139
Dried sucralfate gel retaining the colloidal properties of sucralfate moist gel 138
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 137
Primary microparticles and agglomerates of morphine for nasal insufflation 137
INSULIN HIGHLY RESPIRABLE MICROPARTICLES 137
Effect of drying methods on retention of moist sucralfate gel properties 137
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 136
Modular systems fitted together for the controlled release of substances 134
Effect of electroosmotic flow on permeation and skin accumulation of acyclovir during transdermal iontophoresis 134
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 134
New modules, new assembly kits and new assembles for controlled release of substances 133
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate 133
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 132
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 132
New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin 131
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 130
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 130
Distribution of khellin in excised human skin following iontophoresis and passive dermal transport 130
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 129
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 129
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 129
Tapioca starch graft copolymers and Dome Matrix® modules assembling technology. I. Effect of module shape on drug release 128
Assay of acyclovir in human skin layers by high-performance liquid chromatography 128
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 128
Film bioadesivo contenente caffeina per il trattamento della cellulite 127
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 126
Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects 126
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 126
Drug Release from Swelling-Controlled Systems 125
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 125
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 125
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 125
Totale 15.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.402 0 14 12 62 51 83 154 226 63 95 141 501
2022/20235.025 627 543 297 320 415 575 81 269 1.748 26 98 26
2023/20241.865 81 215 63 88 153 404 151 133 47 135 157 238
2024/20256.028 116 372 438 360 627 668 144 183 795 593 475 1.257
2025/202612.553 1.139 1.213 1.484 1.135 1.857 740 1.506 399 1.603 889 375 213
2026/20271.030 526 504 0 0 0 0 0 0 0 0 0 0
Totale 36.580